The randomized, controlled study, spanning 27 sites, will examine the long term benefits for approximately 300 patients who received either minimally invasive lumbar decompression or epidural steroid injections. The study aims to supplement existing data on MILD’s efficacy.
“There have been more than 20,000 patients treated with MILD and given the low cost of the procedure, this therapy could provide significant benefits to the healthcare system,” added Peter Staats, MD, a study principal investigator and secretary of the American Society of Interventional Pain Physicians.
More articles on orthopedic devices:
Spine device stock report: 5 key companies
New devices & techniques: Which spine surgery innovations are most exciting for surgeons?
DJO Global names Jeanine Kestler EVP, chief HR officer
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
